GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology.

Implantable lens developer STAAR will fund the repurchase using cash on hand and money generated from business operations.

Ophthalmic technology developer Intalight has received the CE mark for its DREAM OCT (optical coherence tomography) platform ...

OncoHost has won a €2.5m ($2.8m) grant to develop a novel biomarker capable of predicting cancer patient responses to immunotherapy.

Abbott's REFLECT studies indicate that FreeStyle Libre use is linked to a decrease in hospitalisation risk for heart ...

Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...

The FDA has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System.